Charles River Laboratories | CRL - Stammkapital





Stammkapital Veränderung Datum
Agilent USD 282.22M 478K 2026-03
Align Technology USD 71.62M 1000 2026-06
Bio-Rad Laboratories USD 26.74M 91K 2026-06
Bruker USD 152.22M 282K 2026-03
Cardinal Health USD 235M 1000K 2026-03
Charles River Laboratories USD 47.73M 439K 2026-06
Cigna USD 264.6M 1.14M 2026-03
Concord Medical Services Hldg CNY 130.25M 0 2025-12
CVS Health USD 1.28B 5M 2026-06
Danaher USD 702.9M 4.8M 2026-06
Dentsply International USD 199.2M 1.1M 2026-06
Elevance Health USD 216.84M 528K 2026-06
Humana USD 120.08M 18K 2026-06
Illumina USD 151.3M 607K 2026-06
Incyte USD 200.98M 1.03M 2026-06
Intrexon USD 0 0 2024-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Laboratory Of America USD 80.9M 1.4M 2026-06
Lakefront Biotherapeutics EUR 65.9M 0 2026-03
Lonza CHF 68.64M 0 2025-12
McKesson USD 116M 4M 2026-06
Merck EUR 434.78M 0 2026-03
Mettler Toledo International USD 20.21M 40.9K 2026-06
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 0 2026-06
Quest Diagnostics USD 110M 1000K 2026-06
Revvity USD 111.63M 174K 2026-06
Thermo Fisher Scientific USD 371.62M 1000 2026-06
United Therapeutics USD 42.68M 521K 2026-06
UnitedHealth USD 908.14M 468K 2026-06
Veradigm USD 106.07M 103.28M 2022-12
Waters USD 98.19M 20K 2026-06
West Pharmaceutical Services USD 70.4M 500K 2026-06